Draft v4 FY26 Investor Presentation 25 August 2026 Infection prevention. For life. Michael Kavanagh CEO & President Jason Burriss CFO Protecting 31 million patients every year Nanosonics develops transformative technologies in medical device reprocessing to improve patient...
2026 Investor Presentation
Filed with ASX ·
Watch Nanosonics' latest callNanosonics (ASX:NAN) Q2 2026 Earnings Call · Replay · Feb 23Read the transcript of Nanosonics (ASX:NAN) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
In the deck
Earlier from Nanosonics
- 2026 Annual Report
- 2026 Sustainability Report
- 2026 Corporate Governance Statement
- Appendix 4E
- FY26 Full Year Results webinar notification
Later from Nanosonics
- Nanosonics to commence $40 million share buy-back program
- 2026 Full Year Financial Results
- Appendix 4G
- Notification of buy-back - NAN
- Change of Director's Interest Notice
Follow Nanosonics into a list and get an email when it puts out news.
Follow Nanosonics